XHKG8437
Market cap2mUSD
Dec 20, Last price
0.27HKD
1D
-1.85%
1Q
1,458.82%
IPO
-53.51%
Name
RMH Holdings Ltd
Chart & Performance
P/E
—
P/S
0.97
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
16.91%
Rev. gr., 5y
-14.57%
Revenues
3m
-25.02%
Net income
-7m
L-72.95%
CFO
781k
P
Earnings
Jun 17, 2025
Profile
RMH Holdings Limited, an investment holding company, provides medical, dermatological, and aesthetic products and services in Singapore, Hong Kong, and internationally. The company operates in two segments, Healthcare service and Trading sales. It provides specialty care services for various dermatological conditions affecting skin, hair, and nails through medical, surgical, laser, and aesthetic treatments. The company also engages in treating skin cancer and skin diseases, such as eczema, psoriasis, acne, pigmentation, adverse drug reactions, and warts; and providing consultancy, prescription, and dispensing services. In addition, it engages in the trading of health supplement products and medical products, including hand sanitizers, disposal medical masks, and other medical products. The company operates seven dermatology and surgery clinics, one aesthetic and laser center, one multi-specialists center, and one regenerative medicine center. RMH Holdings Limited was incorporated in 2017 and is headquartered in Singapore.
Valuation
Title SGD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
| Income | |||||||||
Revenues | 3,180 -25.02% | 4,241 -58.78% | 10,289 31.76% | ||||||
Cost of revenue | 4,000 | 3,534 | 2,280 | ||||||
Unusual Expense (Income) | |||||||||
NOPBT | (820) | 707 | 8,009 | ||||||
NOPBT Margin | 16.67% | 77.84% | |||||||
Operating Taxes | 11,827 | (86) | |||||||
Tax Rate | 1,672.84% | ||||||||
NOPAT | (820) | (11,120) | 8,095 | ||||||
Net income | (6,749) -72.95% | (24,954) 184.05% | (8,785) -5.25% | ||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | 336 | 7,828 | 7,998 | ||||||
BB yield | -6.07% | ||||||||
| Debt | |||||||||
Debt current | 258 | 1,798 | 3,853 | ||||||
Long-term debt | 258 | 3,740 | 13,273 | ||||||
Deferred revenue | |||||||||
Other long-term liabilities | 1,425 | 2,493 | 277 | ||||||
Net debt | 210 | 3,419 | 14,372 | ||||||
| Cash flow | |||||||||
Cash from operating activities | 781 | (5,086) | (6,128) | ||||||
CAPEX | (397) | (1,326) | (1,202) | ||||||
Cash from investing activities | 1,522 | (3,278) | (506) | ||||||
Cash from financing activities | (2,464) | 6,653 | 3,817 | ||||||
FCF | 7,489 | 2,145 | 8,324 | ||||||
| Balance | |||||||||
Cash | 306 | 2,119 | 2,754 | ||||||
Long term investments | |||||||||
Excess cash | 147 | 1,907 | 2,240 | ||||||
Stockholders' equity | (39,259) | (30,145) | (12,444) | ||||||
Invested Capital | 28,423 | 29,202 | 28,325 | ||||||
ROIC | 32.43% | ||||||||
ROCE | 7.57% | 50.43% | |||||||
| EV | |||||||||
Common stock shares outstanding | 1,331,359 | 1,173,750 | 954,947 | ||||||
Price | 0.14 -59.41% | ||||||||
Market cap | 131,783 -36.43% | ||||||||
EV | 146,155 | ||||||||
EBITDA | 983 | 4,465 | 11,765 | ||||||
EV/EBITDA | 12.42 | ||||||||
Interest | 55 | 218 | 340 | ||||||
Interest/NOPBT | 30.83% | 4.25% | |||||||